Partilhar
Informação da revista
Os mais lidos
6945
Cardiopulmonary exercise testing in clinical practice: Principles, applications, and basic interpretationHélder Dores, Miguel Mendes, Ana Abreu, Anaí Durazzo, Cidália Rodrigues, Eduardo Vilela, Gonçalo Cunha, José Gomes Pereira, ... Mário Santos
Rev Port Cardiol. 2024;43:525-36
6945
Acesso de texto completo
5251
Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of CardiologyMiguel Nobre Menezes, Marta Tavares da Silva, Andreia Magalhães, Bruno Melica, Júlia Cristina Toste, Rita Calé, Manuel Almeida, Manuela Fiuza, Eduardo Infante de Oliveira
Rev Port Cardiol. 2024;43:35-48
5251
Acesso de texto completo
3436
RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the oneRodolfo P. Rothlin, Facundo Pelorosso, Mariano Duarte, Liliana Nicolosi, Ignacio Fernandez Criado, María Victoria Salgado, Héctor Vetulli
Rev Port Cardiol. 2024;43:219-20
3436
Acesso de texto completo
3158
Cardiovascular risk assessment using SCORE2 in a population with hypertension – The reality at a primary health care unitSara Pereira Santos, Sara Guedes, Ricardo Pesqueira, João Stuart, Ana M. Carvalho, Patrícia Correia, Isabel Lourenço Ribeiro, Ângela M. Teixeira
Rev Port Cardiol. 2024;43:601-10
3158
Acesso de texto completo
3125
Cardiovascular benefits of resistance exercise: It's time to prescribeHélder Dores, Mafalda Antunes, Daniel Caldeira, Hugo V. Pereira
Rev Port Cardiol. 2024;43:573-82
3125
Acesso de texto completo
3051
Cardiovascular risk assessment in Portugal's primary health care system: SCORE vs. SCORE2Cristina Silva, José Eduardo Mendes, Ricardo Ramos, Amélia Gaspar, Filipe Leal, Nuno Mendes
Rev Port Cardiol. 2024;43:449-55
3051
Acesso de texto completo
3049
conTemporary reflectiOns regarding heart failure manaGEmenT – How to ovERcome the PorTuguese barriers (TOGETHER-PT)José Silva-Cardoso, Jonathan Santos, Inês Araújo, Aurora Andrade, Pedro Morais Sarmento, Paulo Santos, Brenda Moura, Irene Marques, ... Joana Pimenta
Rev Port Cardiol. 2024;43:225-35
3049
Acesso de texto completo
2946
Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the oneJorge Gonçalves, Catarina D. Santos, Paula Fresco, Fernando Fernandez-Llimos
Rev Port Cardiol. 2024;43:221-2
2946
Acesso de texto completo
2783
Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitusHugo Costa, Miguel Espírito-Santo, João Bispo, João Guedes, Jorge Mimoso, Hugo Palmeiro, Rui Baptista Gonçalves, Hugo Vinhas
Rev Port Cardiol. 2024;43:167-74
2783
Acesso de texto completo
2600
Clips on the X-ray: Expect the unexpectedRita Justo Pereira, Mariana Lemos, Isabel Sampaio Graça, Graça Nogueira, Rui Anjos
Rev Port Cardiol. 2024;43:95-6
2600
Acesso de texto completo
2522
PrOgnosis in Pulmonary Embolism (PoPE): 30-Day mortality risk score based on five admission parametersFilipa Gerardo, Daniel Faria, Pedro Silvério António, João Baltazar Ferreira, Marco Beringuilho, Hilaryano Ferreira, Inês Fialho, Inês Miranda, ... João B. Augusto
Rev Port Cardiol. 2024;43:1-8
2522
Acesso de texto completo
2516
Home- versus centre-based EXercise InTervention in patients with Heart Failure (EXIT-HF trial): A pragmatic randomized controlled trialCristine Schmidt, Sandra Magalhães, Priscilla Gois Basilio, Marisol Gouveia, Manuel Teixeira, Cláudio Santos, Aida Isabel Tavares, João Pedro Ferreira, ... Mário Santos
Rev Port Cardiol. 2024;43:149-58
2516
Acesso de texto completo
2489
High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in PortugalKashish Zehra Manjee, Danish Hassan
Rev Port Cardiol. 2024;43:299-300
2489
Acesso de texto completo
2484
Cirrhotic cardiomyopathy: Pathogenesis, clinical features, diagnosis, treatment and prognosisFrancisca Almeida, Alexandra Sousa
Rev Port Cardiol. 2024;43:203-12
2484
Acesso de texto completo
2443
Effectiveness and safety of non-invasive ventilation in the management of cardiogenic shockLuna Carrillo-Aleman, Angel Andres Agamez-Luengas, Miguel Guia, Ana Renedo-Villarroya, Nuria Alonso-Fernández, Laura Lopez-Gomez, Pablo Bayoumy-Delis, Juan M. Sanchez-Nieto, ... Andrés Carrillo-Alcaraz
Rev Port Cardiol. 2024;43:259-73
2443
Acesso de texto completo
2382
The culprit of uncontrolled hypertension: A case of monoamine oxidase inhibitor and clonidine interactionLinfang Deng, Lihua Shi, Xiaolan Ye
Rev Port Cardiol. 2024;43:223-4
2382
Acesso de texto completo
2367
Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?Joana Delgado-Silva
Rev Port Cardiol. 2024;43:175-6
2367
Acesso de texto completo
2257
Assessment of subtle cardiac dysfunction induced by premature ventricular contraction using two-dimensional strain echocardiography and the effects of successful ablationZeki Doğan, Emine Çakcak Erden, İsmail Erden, Gökhan Bektaşoğlu
Rev Port Cardiol. 2024;43:25-32
2257
Acesso de texto completo
2240
Training and attitudes concerning cardiac rehabilitation in Portugal: A national survey of physician members of the Portuguese Society of CardiologyEduardo M. Vilela, Luísa Bento, Luís Oliveira, Ana Abreu, Hélder Dores, Madalena Teixeira, Miguel Mendes, Paulo Fontes, ... Lino Gonçalves
Rev Port Cardiol. 2024;43:487-96
2240
Acesso de texto completo
2197
Loop diuretic discontinuation in chronic heart failure patients: A retrospective studyGonçalo Silva, Brenda Moura, Emília Moreira, Cláudia Camila Dias, Bernardo Sousa Pinto, Manuel Campelo, Sandra Amorim, Elisabete Martins, ... José Silva Cardoso
Rev Port Cardiol. 2024;43:513-22
2197
Acesso de texto completo
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.